HemaSphere
(Aug 2023)
PB2051: POPULATION PHARMACOKINETIC/PHARMACODYNAMIC/EFFICACY MODELING OF SB12 (PROPOSED ECULIZUMAB BIOSIMILAR) AND REFERENCE ECULIZUMAB
- Hyuna Lee,
- Jihye Park,
- Hyerin Jang,
- Jungryul Kim
Affiliations
- Hyuna Lee
- 1 Samsung Bioepis, Clinical development, Korea, Rep. of South
- Jihye Park
- 1 Samsung Bioepis, Clinical development, Korea, Rep. of South
- Hyerin Jang
- 1 Samsung Bioepis, Clinical development, Korea, Rep. of South
- Jungryul Kim
- 2 Samsung Medical Center, Department of Clinical Pharmacology and Therapeutics, Seoul, Korea, Rep. of South
- DOI
-
https://doi.org/10.1097/01.HS9.0000975004.91980.ef
- Journal volume & issue
-
Vol. 7
p.
e91980ef
WeChat QR code